Published mark
Pfizer
PFIZER INC
NYSE: PFE. Pfizer Inc. is a global biopharmaceutical leader engaged in the research, development, production, marketing, and distribution of a wide array of medicinal and vaccine products worldwide.
US
Record source reportedRecord not claimedNo Eval published
- Alpha ID
- alpha:company:f04775b0-a6e0-4f9c-b07b-2e15fc8e88c8
- SEC CIK
- 0000078003
- Website
- www.pfizer.com Open
- Record version
- vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce, published Oct 15, 2026
- Newest evidence
- May 3, 2026
- Monitoring
- Not yet monitored Details
- Integrity
- Not yet signed Methodology
- CEO
- Albert BourlaChairman of the Board and Chief Executive Officer
- Chair
- Albert BourlaLead independent: Shantanu Narayen
- Independent
- Not published11 directors published
- Published claims
- 685 distinct sources
- Evidence records
- 290 pinned
- Source conflicts
- 0None open
Built from 5 distinct sources and 29 evidence records. Every Claim links to where it appears. Where nothing was published, the record states the coverage gap.
CorroboratedSource reportedAlpha inferenceNot disclosed
Public record. Alpha publishes governance facts about this organization from regulatory filings and company statements. Private enterprise overlay data is never projected here. The company can claim the record, correct, or dispute any Claim. How this works
DIRECTOR APPOINTED
Cyrus Taraporevala seat on Pfizer, effective 2024-01-01.
EffectiveEffective Jan 1, 2024E4
Monitoring
ContinuousWhat the published record states about identity, evidence, evaluation, monitoring, authority, and freshness. Watched-source schedules are not published for this record.
- IdentityunclaimedPublished
- Evidencesource_reportedPublished
- Evaluationnot_evaluatedPublished
- MonitoringNot yet published for this record.Not published
- AuthorityNot yet published for this record.Not published
- FreshnesscurrentPublished
Leadership
Evidence| Role | Person | Since | Status | Claim |
|---|---|---|---|---|
| Chief U.S. Commercial Officer, Executive Vice President | Aamir Malik | Not captured | unknown | Source reportedE15 |
| Chairman of the Board and Chief Executive Officer | Albert Bourla | Not captured | unknown | Source reportedE16 |
| Chairman of the Board and Chief Executive Officer | Albert Bourla, DVM, Ph.D. | Not captured | unknown | Source reportedE17 |
| Chief International Commercial Officer, Executive Vice President | Alexandre de Germay | Not captured | unknown | Source reportedE18 |
| Chief Strategy and Innovation Officer and Executive Vice President | Andrew Baum | Not captured | unknown | Source reportedE19 |
| Chief Strategy and Innovation Officer and Executive Vice President | Andrew Baum, MA, BM ChB | Not captured | unknown | Source reportedE20 |
| Chief Scientific Officer and President, Research Development | Chris Boshoff | Not captured | unknown | Source reportedE21 |
| Chief Scientific Officer and President, Research Development | Chris Boshoff, MD, FRCP, FMedSci, Ph.D. | Not captured | unknown | Source reportedE22 |
| Chief Financial Officer, Executive Vice President | David M. Denton | Not captured | unknown | Source reportedE23 |
| Chief Legal Officer, Executive Vice President | Douglas M. Lankler | Not captured | unknown | Source reportedE24 |
| Chief Digital and Technology Officer, Executive Vice President | Lidia Fonseca | Not captured | unknown | Source reportedE25 |
| Chief Global Supply and Quality Officer, Executive Vice President | Michael McDermott | Not captured | unknown | Source reportedE26 |
| Chief People Experience Officer, Executive Vice President | Payal Sahni | Not captured | unknown | Source reportedE27 |
Board of directors
Evidence11 directors published. Independence determinations are not published for every director.
| Director | Status | Since | Committees | Claim |
|---|---|---|---|---|
| Albert Bourla | Independence not publishedChair | 2018 | Other Public Boards | Source reportedE3 |
| Cyrus Taraporevala | Independence not published | 2024 | AuditAudit; CompensationCompensation | Source reportedE4 |
| Dan R. Littman | Independence not published | 2018 | GovernanceGovernance; Regulatory and Compliance; Science and Technology; Other Public Boards; RiskOther Public BoardsRegulatory and ComplianceRiskScience and Technology | Source reportedE5 |
| James C. Smith | Independence not published | 2014 | AuditAudit; Compensation · Chair; Other Public BoardsCompensation, chairOther Public Boards | Source reportedE6 |
| James Quincey | Independence not published | 2020 | Compensation | Source reportedE7 |
| Joseph J. Echevarria | Independence not published | 2015 | AuditAudit; Governance · ChairGovernance, chair | Source reportedE8 |
| Mortimer J. Buckley | Independence not published | 2024 | AuditAudit; GovernanceGovernance | Source reportedE9 |
| Ronald E. Blaylock | Independence not published | 2017 | AuditAudit; CompensationCompensation | Source reportedE10 |
| Shantanu Narayen | Independence not publishedLead Independent | 2013 | None published | Source reportedE12 |
| Susan Desmond-Hellmann | Independence not published | 2020 | GovernanceGovernance; Science and Technology · Chair; Other Public BoardsOther Public BoardsScience and Technology, chair | Source reportedE13 |
| Suzanne Nora Johnson | Independence not published | 2007 | Audit, chairAudit · Chair; Regulatory and ComplianceRegulatory and Compliance | Source reportedE14 |
| Scott Gottlieb | Independence not published | Not published | Regulatory and ComplianceRisk, chairScience and Technology | Source reportedE28 |
| Scott Gottlieb, M.D. | Independent | Not published | None published | Source reportedE11 |
Committees and risk ownership
Evidence| Committee | Chair | Members | Risks assigned |
|---|---|---|---|
| Audit | Suzanne Nora Johnson | Suzanne Nora Johnson, Cyrus Taraporevala, James C. Smith, Joseph J. Echevarria, Mortimer J. Buckley, Ronald E. Blaylock | Not described in the published record |
| Audit · Chair; Regulatory and Compliance | Not published | Suzanne Nora Johnson | regulatory |
| Audit; Compensation | Not published | Cyrus Taraporevala, Ronald E. Blaylock | Not described in the published record |
| Audit; Compensation · Chair; Other Public Boards | Not published | James C. Smith | Not described in the published record |
| Audit; Governance | Not published | Mortimer J. Buckley | Not described in the published record |
| Audit; Governance · Chair | Not published | Joseph J. Echevarria | Not described in the published record |
| Compensation | James C. Smith | James C. Smith, Cyrus Taraporevala, James Quincey, Ronald E. Blaylock | Not described in the published record |
| Governance | Joseph J. Echevarria | Joseph J. Echevarria, Dan R. Littman, Mortimer J. Buckley, Susan Desmond-Hellmann | Not described in the published record |
| Governance; Regulatory and Compliance; Science and Technology; Other Public Boards; Risk | Not published | Dan R. Littman | regulatory |
| Governance; Science and Technology · Chair; Other Public Boards | Not published | Susan Desmond-Hellmann | Not described in the published record |
| Other Public Boards | Not published | Albert Bourla, Dan R. Littman, James C. Smith, Susan Desmond-Hellmann | Not described in the published record |
| Regulatory and Compliance | Not published | Dan R. Littman, Scott Gottlieb, Suzanne Nora Johnson | regulatory |
| Risk | Scott Gottlieb | Scott Gottlieb, Dan R. Littman | Not described in the published record |
| Science and Technology | Susan Desmond-Hellmann | Susan Desmond-Hellmann, Dan R. Littman, Scott Gottlieb | Not described in the published record |
Committee RecordAudit: Chair Suzanne Nora Johnson; Members Suzanne Nora Johnson (Chair); Cyrus Taraporevala; James C. Smith; Joseph J. Echevarria; Mortimer J. Buckley; Ronald E. Blaylock
Committee AppointmentSuzanne Nora Johnson: chair, Audit
Committee AppointmentCyrus Taraporevala: member, Audit
Committee AppointmentJames C. Smith: member, Audit
Committee AppointmentJoseph J. Echevarria: member, Audit
Committee AppointmentMortimer J. Buckley: member, Audit
Committee AppointmentRonald E. Blaylock: member, Audit
Committee RecordCompensation: Chair James C. Smith; Members James C. Smith (Chair); Cyrus Taraporevala; James Quincey; Ronald E. Blaylock
Committee AppointmentJames C. Smith: chair, Compensation
Committee AppointmentCyrus Taraporevala: member, Compensation
Committee AppointmentJames Quincey: member, Compensation
Committee AppointmentRonald E. Blaylock: member, Compensation
Committee RecordGovernance: Chair Joseph J. Echevarria; Members Joseph J. Echevarria (Chair); Dan R. Littman; Mortimer J. Buckley; Susan Desmond-Hellmann
Committee AppointmentJoseph J. Echevarria: chair, Governance
Committee AppointmentDan R. Littman: member, Governance
Committee AppointmentMortimer J. Buckley: member, Governance
Committee AppointmentSusan Desmond-Hellmann: member, Governance
Committee RecordOther Public Boards: Chair not stated; Members Albert Bourla; Dan R. Littman; James C. Smith; Susan Desmond-Hellmann
Committee AppointmentAlbert Bourla: member, Other Public Boards
Committee AppointmentDan R. Littman: member, Other Public Boards
Committee AppointmentJames C. Smith: member, Other Public Boards
Committee AppointmentSusan Desmond-Hellmann: member, Other Public Boards
Committee AppointmentDan R. Littman: member, Regulatory and Compliance
Committee AppointmentScott Gottlieb: member, Regulatory and Compliance
Committee AppointmentSuzanne Nora Johnson: member, Regulatory and Compliance
Committee RecordRisk: Chair Scott Gottlieb; Members Scott Gottlieb (Chair); Dan R. Littman
Committee AppointmentScott Gottlieb: chair, Risk
Committee AppointmentDan R. Littman: member, Risk
Committee RecordScience and Technology: Chair Susan Desmond-Hellmann; Members Susan Desmond-Hellmann (Chair); Dan R. Littman; Scott Gottlieb
Committee AppointmentSusan Desmond-Hellmann: chair, Science and Technology
Committee AppointmentDan R. Littman: member, Science and Technology
Committee AppointmentScott Gottlieb: member, Science and Technology
Control and voting power
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Authority to act
Evidence and agent registryWho can act for the company, and on whose authority. This is what a counterparty's agent checks before it accepts an order, signs, or pays.
Principal executive officerAlbert Bourla, Chairman of the Board and Chief Executive Officer
Who can authorize an agentNot assessedNo Alpha inference about signing authority or board-reserved matters is published for this record.
Not assessed
AI agents registered by the companyNot registered in the public RegistryAgent Deployments, Agent Use Cases, Authority Grants, TrustChecks, Action Ledger entries and Governance Receipts live in the private enterprise overlay. They are never projected into the public Registry without explicit cross-plane authorization. Absence here is a plane boundary, not evidence that the enterprise operates no agents.
Agent registry
Delegations publishedNot disclosedBoard and officer delegation resolutions are not public filings and are not published in this record.
Search scope
Financials and market context
EvidenceIndex MembershipS&P 500 (SPX)
Security ListingPFE (NYSE)
Index memberships1 membership attached to a specific security and listing.Announcements, effective dates, and removals remain distinct states; Alpha does not infer membership from company size, exchange, or reputation.
SPX
Source reportedAs of Oct 15, 2026. Rights-filtered public evidence only; no redistribution or model training is granted. Only source-backed memberships with an explicit public redistribution basis are returned.
| Index | Security | Status | Effective | Verification | Source |
|---|---|---|---|---|---|
| S&P 500 (S&P Dow Jones Indices) | NYSE: PFE | current | Mar 4, 1957 | inferred | Slickcharts S&P 500 constituent table (public observation, not S&P DJI license) |
Governance and policies
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Risk, audit, and cyber
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
AI oversight and accountability
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Legal and regulatory
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Compensation
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Other published claims
EvidencePublished Claims that belong to no section above. Each keeps its permalink, evidence, and assertion state.
Legal NamePFIZER INC
Entity StatusPublic listing published
Official Websitehttps://www.pfizer.com
Published FactUS
Published FactDE
Published FactHealthcare
Published FactDrug Manufacturers
Published Facthttps://www.pfizer.com
Not yet in this record
CoverageA gap is a coverage state, not a negative finding. These sections are expected for this entity class and are not yet published.
- Corporate structureNot reviewed. Parent, subsidiary and predecessor structure explains who is governed.
- OwnershipNot reviewed. Ownership and voting power determine who can influence the board.
- FinancialsNot reviewed. Governance-relevant financial context frames capital and audit decisions.
- CompensationNot reviewed. Pay design shows how incentives are governed.
- GovernanceNot reviewed. Governing documents and provisions set the rules of the enterprise.
- Shareholder governanceNot reviewed. Meeting and vote records show shareholder dissent and support.
- AuditNot reviewed. Auditor, controls and restatements show assurance over reporting.
- LegalNot reviewed. Material legal and regulatory matters show enforcement exposure.
- RiskNot reviewed. Risk ownership links the board, committees, executives and controls.
- CyberNot reviewed. Cyber and data governance is a disclosed oversight domain.
- AI governanceNot reviewed. AI oversight is a differentiated Alpha governance domain.
- Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.
- Only explicitly published canonical company identity and current confirmed public roles are included.Only explicitly published canonical company identity and current confirmed public roles are included.
- Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.
- Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.
- This Company Profile is an identity and evidence record, not an Alpha rating.This Company Profile is an identity and evidence record, not an Alpha rating.
Linked people
Same claims as person records- Aamir MalikChief U.S. Commercial Officer, Executive Vice Presidentcompany:f04775b0-a6e0-4f9c-b07b-2e15fc8e88c8:leadership_role:22
- Albert BourlaChairman of the Board and Chief Executive Officercompany:f04775b0-a6e0-4f9c-b07b-2e15fc8e88c8:leadership_role:23, company:f04775b0-a6e0-4f9c-b07b-2e15fc8e88c8:leadership_role:10
- Albert Bourla, DVM, Ph.D.Chairman of the Board and Chief Executive Officercompany:f04775b0-a6e0-4f9c-b07b-2e15fc8e88c8:leadership_role:24
- Alexandre de GermayChief International Commercial Officer, Executive Vice Presidentcompany:f04775b0-a6e0-4f9c-b07b-2e15fc8e88c8:leadership_role:25
- Andrew BaumChief Strategy and Innovation Officer and Executive Vice Presidentcompany:f04775b0-a6e0-4f9c-b07b-2e15fc8e88c8:leadership_role:26
- Andrew Baum, MA, BM ChBChief Strategy and Innovation Officer and Executive Vice Presidentcompany:f04775b0-a6e0-4f9c-b07b-2e15fc8e88c8:leadership_role:27
- Chris BoshoffChief Scientific Officer and President, Research Developmentcompany:f04775b0-a6e0-4f9c-b07b-2e15fc8e88c8:leadership_role:28
- Chris Boshoff, MD, FRCP, FMedSci, Ph.D.Chief Scientific Officer and President, Research Developmentcompany:f04775b0-a6e0-4f9c-b07b-2e15fc8e88c8:leadership_role:29
- David M. DentonChief Financial Officer, Executive Vice Presidentcompany:f04775b0-a6e0-4f9c-b07b-2e15fc8e88c8:leadership_role:30
- Douglas M. LanklerChief Legal Officer, Executive Vice Presidentcompany:f04775b0-a6e0-4f9c-b07b-2e15fc8e88c8:leadership_role:31
- Lidia FonsecaChief Digital and Technology Officer, Executive Vice Presidentcompany:f04775b0-a6e0-4f9c-b07b-2e15fc8e88c8:leadership_role:32
- Michael McDermottChief Global Supply and Quality Officer, Executive Vice Presidentcompany:f04775b0-a6e0-4f9c-b07b-2e15fc8e88c8:leadership_role:33
- Payal SahniChief People Experience Officer, Executive Vice Presidentcompany:f04775b0-a6e0-4f9c-b07b-2e15fc8e88c8:leadership_role:34
- Cyrus TaraporevalaDirectorcompany:f04775b0-a6e0-4f9c-b07b-2e15fc8e88c8:leadership_role:11
- Dan R. LittmanDirectorcompany:f04775b0-a6e0-4f9c-b07b-2e15fc8e88c8:leadership_role:12
- James C. SmithDirectorcompany:f04775b0-a6e0-4f9c-b07b-2e15fc8e88c8:leadership_role:13
- James QuinceyDirectorcompany:f04775b0-a6e0-4f9c-b07b-2e15fc8e88c8:leadership_role:14
- Joseph J. EchevarriaDirectorcompany:f04775b0-a6e0-4f9c-b07b-2e15fc8e88c8:leadership_role:15
- Mortimer J. BuckleyDirectorcompany:f04775b0-a6e0-4f9c-b07b-2e15fc8e88c8:leadership_role:16
- Ronald E. BlaylockDirectorcompany:f04775b0-a6e0-4f9c-b07b-2e15fc8e88c8:leadership_role:17
- Shantanu NarayenLead Independent Directorcompany:f04775b0-a6e0-4f9c-b07b-2e15fc8e88c8:leadership_role:19
- Susan Desmond-HellmannDirectorcompany:f04775b0-a6e0-4f9c-b07b-2e15fc8e88c8:leadership_role:20
- Suzanne Nora JohnsonDirectorcompany:f04775b0-a6e0-4f9c-b07b-2e15fc8e88c8:leadership_role:21
- Scott GottliebDirector (committee appointment)company:f04775b0-a6e0-4f9c-b07b-2e15fc8e88c8:committee_record:57
- Scott Gottlieb, M.D.Independent Directorcompany:f04775b0-a6e0-4f9c-b07b-2e15fc8e88c8:leadership_role:18
Subject and corrections
Public-role doctrineThis record exists because the company is in the published Registry. The company can claim the record, correct, or dispute any Claim. Corrections are versioned and the original stays in history.
- Basis
- Published company record built from public sources
- Sources
- 29 evidence records cited. 0 with redistribution rights.
- Never published
- Private enterprise overlay data: deployments, authority grants, TrustChecks, receipts, telemetry
- Record claimed
- No
- Open disputes
- 0
- Identity ownership
- unclaimed
Claiming not yet available
If the company claims the record, its statements appear as their own assertion state and never overwrite the cited evidence.
Evidence
Authority and rights- E1Alpha canonical company public projection. canonical identity. Retrieved Oct 15, 2026. Cited by 7 Claims.
- E2PFIZER INC Form 10-K (filed 2026-02-26). SEC filing. Retrieved Aug 29, 2026. Cited by 2 Claims.
- E3sec filing. Published Mar 12, 2026. Retrieved May 3, 2026. Cited by 1 Claim.
- E4sec filing. Published Mar 12, 2026. Retrieved May 3, 2026. Cited by 1 Claim.
- E5sec filing. Published Mar 12, 2026. Retrieved May 3, 2026. Cited by 1 Claim.
- E6sec filing. Published Mar 12, 2026. Retrieved May 3, 2026. Cited by 1 Claim.
- E7sec filing. Published Mar 12, 2026. Retrieved May 3, 2026. Cited by 1 Claim.
- E8sec filing. Published Mar 12, 2026. Retrieved May 3, 2026. Cited by 1 Claim.
- E9sec filing. Published Mar 12, 2026. Retrieved May 3, 2026. Cited by 1 Claim.
- E10sec filing. Published Mar 12, 2026. Retrieved May 3, 2026. Cited by 1 Claim.
- E11sec proxy. Published Mar 12, 2026. Retrieved Mar 21, 2026. Cited by 1 Claim.
- E12sec filing. Published Mar 12, 2026. Retrieved May 3, 2026. Cited by 1 Claim.
- E13sec filing. Published Mar 12, 2026. Retrieved May 3, 2026. Cited by 1 Claim.
- E14sec filing. Published Mar 12, 2026. Retrieved May 3, 2026. Cited by 1 Claim.
- E15PFE executive roster sourcesec filing. Published May 3, 2026. Retrieved May 3, 2026. Cited by 1 Claim.
- E16PFE executive roster sourcesec filing. Published May 3, 2026. Retrieved May 3, 2026. Cited by 1 Claim.
- E17PFE executive roster sourcesec filing. Published May 3, 2026. Retrieved May 3, 2026. Cited by 1 Claim.
- E18PFE executive roster sourcesec filing. Published May 3, 2026. Retrieved May 3, 2026. Cited by 1 Claim.
- E19PFE executive roster sourcesec filing. Published May 3, 2026. Retrieved May 3, 2026. Cited by 1 Claim.
- E20PFE executive roster sourcesec filing. Published May 3, 2026. Retrieved May 3, 2026. Cited by 1 Claim.
- E21PFE executive roster sourcesec filing. Published May 3, 2026. Retrieved May 3, 2026. Cited by 1 Claim.
- E22PFE executive roster sourcesec filing. Published May 3, 2026. Retrieved May 3, 2026. Cited by 1 Claim.
- E23PFE executive roster sourcesec filing. Published May 3, 2026. Retrieved May 3, 2026. Cited by 1 Claim.
- E24PFE executive roster sourcesec filing. Published May 3, 2026. Retrieved May 3, 2026. Cited by 1 Claim.
- E25PFE executive roster sourcesec filing. Published May 3, 2026. Retrieved May 3, 2026. Cited by 1 Claim.
- E26PFE executive roster sourcesec filing. Published May 3, 2026. Retrieved May 3, 2026. Cited by 1 Claim.
- E27PFE executive roster sourcesec filing. Published May 3, 2026. Retrieved May 3, 2026. Cited by 1 Claim.
- E28board_seats. sp500-board-director-completeness-remediation-2026-05-15. Cited by 33 Claims.
- E29Slickcharts S&P 500 constituent table (public observation, not S&P DJI license). index provider. Retrieved Sep 2, 2026. Cited by 1 Claim.
What changed in version public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce
vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce published Oct 15, 2026- Cyrus Taraporevala seat on Pfizer, effective 2024-01-01.
- Mortimer J. Buckley seat on Pfizer, effective 2024-01-01.
- Audit; Compensation committee of Pfizer, effective 2024-01-01.
- Cyrus Taraporevala member of Audit; Compensation, effective 2024-01-01.
- Audit; Governance committee of Pfizer, effective 2024-01-01.
- Mortimer J. Buckley member of Audit; Governance, effective 2024-01-01.
- James Quincey seat on Pfizer, effective 2020-01-01.
- Susan Desmond-Hellmann seat on Pfizer, effective 2020-01-01.
- Governance; Science and Technology · Chair; Other Public Boards committee of Pfizer, effective 2020-01-01.
- Susan Desmond-Hellmann member of Governance; Science and Technology · Chair; Other Public Boards, effective 2020-01-01.
- Albert Bourla seat on Pfizer, effective 2018-01-01.
- Albert Bourla chairs board Pfizer, effective 2018-01-01.
- Dan R. Littman seat on Pfizer, effective 2018-01-01.
- Governance; Regulatory and Compliance; Science and Technology; Other Public Boards; Risk committee of Pfizer, effective 2018-01-01.
- Dan R. Littman member of Governance; Regulatory and Compliance; Science and Technology; Other Public Boards; Risk, effective 2018-01-01.
- Albert Bourla member of Other Public Boards, effective 2018-01-01.
- Ronald E. Blaylock seat on Pfizer, effective 2017-01-01.
- Ronald E. Blaylock member of Audit; Compensation, effective 2017-01-01.
- Joseph J. Echevarria seat on Pfizer, effective 2015-01-01.
- Audit; Governance · Chair committee of Pfizer, effective 2015-01-01.
- Joseph J. Echevarria member of Audit; Governance · Chair, effective 2015-01-01.
- James C. Smith seat on Pfizer, effective 2014-01-01.
- Audit; Compensation · Chair; Other Public Boards committee of Pfizer, effective 2014-01-01.
- James C. Smith member of Audit; Compensation · Chair; Other Public Boards, effective 2014-01-01.
- Shantanu Narayen seat on Pfizer, effective 2013-01-01.
- Shantanu Narayen lead independent director of Pfizer, effective 2013-01-01.
- Suzanne Nora Johnson seat on Pfizer, effective 2007-01-01.
- Audit · Chair; Regulatory and Compliance committee of Pfizer, effective 2007-01-01.
- Suzanne Nora Johnson member of Audit · Chair; Regulatory and Compliance, effective 2007-01-01.